HANGZHOU RONGZE BIOTECHNOLOGY GROUP CO LTD
Overview
HANGZHOU RONGZE BIOTECHNOLOGY GROUP CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering MESENCHYMAL STEM CELL EXPANSION KIT.
API / Drug Master Files
HANGZHOU RONGZE BIOTECHNOLOGY GROUP CO LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- MESENCHYMAL STEM CELL EXPANSION KITActive2021-11-22
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to HANGZHOU RONGZE BIOTECHNOLOGY GROUP CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.